Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-23-010519

Chief Executive Officer sold 5,675 shares at $206.95 ($1,174,451)

  • Chief Executive Officer acquired 5,675 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Farrell Michael J. Chief Executive Officer 2023-03-15 Option exercise +5,675 $57.76 $327,788 442,575 D
Farrell Michael J. Chief Executive Officer 2023-03-15 Sale −5,675 $206.95 $1,174,451 436,900 D
Derivatives
Farrell Michael J. Chief Executive Officer 2023-03-15 Option exercise · ResMed Common Stock Options −5,675 48,865 D
Open-market sales · 5,675 sh · avg $206.95 · $1,174,451
Loading xslF345X03/form4.xml…